Head‐and‐neck dermatofibrosarcoma protuberans: Survival analysis and Clinically relevant immunohistochemical indicators
Oral Diseases · 2024
DOI: 10.1111/odi.14495 ↗Kurz gefasst
Fachartikel in der Zeitschrift Oral Diseases, 2024. Verfasst von Zhenlin Dai und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial-Head and Neck Oncology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Chi…. Hauptthemen laut MEDLINE: Dermatofibrosarcoma, Head and Neck Neoplasms, Skin Neoplasms, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Clinical Research Project of Multi-Disciplinary Team, Shanghai Ninth People's Hospital, Shanghai University School of Medicine, National Natural Science Foundation of China, Biobank Program of Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine.
Abstract (Originalsprache)
Background
Head and neck dermatofibrosarcoma protuberans (HNDFSP) is extremely rare and not entirely understood.
Objective
To investigate the clinicopathological features of HNDFSP and identify the expression of its clinically relevant indicators, with the expectation of improving the existing treatment strategies.
Methods
A long‐term follow‐up of patients with HNDFSP who received treatment between 2000 and 2021 at Shanghai Ninth People's Hospital was conducted. The clinical, histological, and immunohistochemical data of the patients were retrieved and analyzed. The endpoint of the study was the incidence of significant disease‐related clinical events (recurrences or metastasis).
Results
A total of 49 patients with HNDFSP were included in the study, with males (92.7%) predominating than females (7.3%). Eighteen patients developed recurrent disease (36.8%) after surgery, and the median time of recurrence was 48 months (interquartile, 20–74 months). Metastasis occurred in two cases (4.1%). Two patients died during follow‐up, both with local recurrence, and one of them with intestinal metastasis. Post‐operation radiotherapy was administered to eight patients (16.3%) and the effect in local control was remarkable. Age, tumor size, and negative margins with sufficient safety width were the main independent factors affecting the disease‐free survival. Several potential targeted therapeutic indicators, including EZH2 (80.0%), EGFR (91.4%), PDGF (97.1%), PD‐L1 (77.1%), and VEGF (77.1%), were positively expressed in most tumor samples.
Conclusion
HNDFSP is rare, significantly challenging to control locally, and has a worse prognosis with current treatment strategies. Wide local excision and long‐term follow‐up are needed. Radiotherapy could improve the prognosis of patients with HNDFSP.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial-Head and Neck Oncology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Shanghai Key Laboratory of Stomatology, Shanghai Research Institute of Stomatology, Shanghai, China.
- National Clinical Research Center for Oral Disease, Shanghai, China.
- Department of Oral Pathology, Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
ORCID-Profile: Zhen Tian, Chunyue Ma, Wei Cao, Tong Ji
Förderung
- Clinical Research Project of Multi-Disciplinary Team, Shanghai Ninth People's Hospital, Shanghai University School of Medicine
- National Natural Science Foundation of China
- Biobank Program of Shanghai Ninth People's Hospital, Shanghai Jiao Tong University School of Medicine
Zitieren
APA
Dai, Z., He, Y., Zhang, X., Tian, Z., Zhu, G., Ren, Z., Ye, L., Liu, Z., Ma, C., Cao, W., & Ji, T. (2024). Head‐and‐neck dermatofibrosarcoma protuberans: Survival analysis and Clinically relevant immunohistochemical indicators. Oral Diseases. https://doi.org/10.1111/odi.14495
Vancouver
Dai Z, He Y, Zhang X, Tian Z, Zhu G, Ren Z, et al. Head‐and‐neck dermatofibrosarcoma protuberans: Survival analysis and Clinically relevant immunohistochemical indicators. Oral Diseases. 2024. doi:10.1111/odi.14495
BibTeX
@article{Dai2024,
author = {Dai, Zhenlin and He, Youya and Zhang, Xu and Tian, Zhen and Zhu, Guopei and Ren, Zhenhu and Ye, Lulu and Liu, Zheqi and Ma, Chunyue and Cao, Wei and Ji, Tong},
title = {Head‐and‐neck dermatofibrosarcoma protuberans: Survival analysis and Clinically relevant immunohistochemical indicators},
journal = {Oral Diseases},
year = {2024},
doi = {10.1111/odi.14495}
}
EUVIMED